Syndax Pharmaceuticals (SNDX) Net Margin Growth (5y) (2020 - 2026)
Syndax Pharmaceuticals (SNDX) Net Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 726,254.00 |
| Dec 31, 2025 | 524,476.00 |
| Sep 30, 2025 | 522,731.00 |
| Jun 30, 2025 | 433,316.00 |
| Mar 31, 2025 | 366,799.00 |
| Dec 31, 2024 | 214,956.00 |
| Sep 30, 2024 | 311,618.00 |
| Jun 30, 2024 | 224,681.00 |
| Dec 31, 2021 | 372,811.00 |
| Sep 30, 2021 | 486,634.00 |
| Jun 30, 2021 | -321,149.00 |
| Mar 31, 2021 | -452,338.00 |
| Dec 31, 2020 | -376,751.00 |
| Sep 30, 2020 | -337,418.00 |
| Jun 30, 2020 | 13.64 Mn |